A new chapter is unfolding for patients with sickle cell disease and beta-thalassemia: breakthroughs in gene regulation are transforming how these conditions are treated. Emerging approaches focus on turning fetal hemoglobin back on by blocking…
Continue Reading
News Source: www.forbes.com
Leave a Reply